Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Current Leases: 2019-2024

Historic Current Leases for Northwest Biotherapeutics (NWBO) over the last 6 years, with Dec 2024 value amounting to $326,000.

  • Northwest Biotherapeutics' Current Leases rose 55.86% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $399,000, marking a year-over-year increase of 55.86%. This contributed to the annual value of $326,000 for FY2024, which is 3.82% up from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Current Leases of $326,000 as of FY2024, which was up 3.82% from $314,000 recorded in FY2023.
  • Over the past 5 years, Northwest Biotherapeutics' Current Leases peaked at $354,000 during FY2022, and registered a low of $167,000 during FY2020.
  • For the 3-year period, Northwest Biotherapeutics' Current Leases averaged around $331,333, with its median value being $326,000 (2024).
  • Its Current Leases has fluctuated over the past 5 years, first crashed by 57.72% in 2020, then surged by 89.82% in 2021.
  • Northwest Biotherapeutics' Current Leases (Yearly) stood at $167,000 in 2020, then soared by 89.82% to $317,000 in 2021, then rose by 11.67% to $354,000 in 2022, then decreased by 11.30% to $314,000 in 2023, then grew by 3.82% to $326,000 in 2024.